No Evidence of Acute Dengue Virus Infections at a Rural Site in Western Kenya, 2011 and 2013.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 3 9 2020
medline: 1 12 2020
entrez: 3 9 2020
Statut: ppublish

Résumé

The incidence and spread of dengue virus (DENV) have increased rapidly in recent decades. Dengue is underreported in Africa, but recent outbreaks and seroprevalence data suggest that DENV is widespread there. A lack of ongoing surveillance limits knowledge about its spatial reach and hinders disease control planning. We sought to add data on dengue distribution in Kenya through diagnostic testing of serum specimens from persons with an acute febrile illness (AFI) attending an outpatient clinic in rural western Kenya (Asembo) during rainy seasons. Patients with symptoms not likely to be misclassified as dengue (e.g., diarrhea and anemia), those with a positive diagnostic laboratory results which explained their febrile illness, or those with serum collected more than 5 days after fever onset were excluded. However, febrile patients with a positive malaria smear were included in the study. We used reverse transcription polymerase chain reaction (RT-PCR) to test for DENV and IgM anti-DENV to test for recent infection. Of the 615 serum specimens available for testing, none were dengue positive by either RT-PCR or IgM anti-DENV testing. Dengue did not appear to be a cause of febrile illness in this area of western Kenya, although our relatively small sample size may not have identified DENV infections occurring at low incidence. A more widespread AFI surveillance system that includes dengue diagnostic testing by RT-PCR and antibody-based methods is required to more definitively gauge the size and geographic distribution of DENV infection in western Kenya.

Identifiants

pubmed: 32876014
doi: 10.4269/ajtmh.20-0132
pmc: PMC7646792
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2054-2058

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR000422
Pays : United States

Références

Lancet. 2014 Oct 11;384(9951):1358-65
pubmed: 25018116
J Clin Microbiol. 1992 Mar;30(3):545-51
pubmed: 1372617
Emerg Infect Dis. 2017 Nov;23(11):1915-1917
pubmed: 29048283
N Engl J Med. 2015 Jan 8;372(2):113-23
pubmed: 25365753
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
PLoS Negl Trop Dis. 2012;6(11):e1908
pubmed: 23209852
Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S30-8
pubmed: 21548185
Am J Clin Pathol. 2010 Sep;134(3):368-73
pubmed: 20716791
PLoS One. 2018 Jun 7;13(6):e0198556
pubmed: 29879159
PLoS One. 2015 Jun 24;10(6):e0128792
pubmed: 26107772
N Engl J Med. 2014 Feb 27;370(9):809-17
pubmed: 24571753
Trop Med Int Health. 2009 Dec;14(12):1542-51
pubmed: 19788717
Indian J Med Res. 2012 Jul;136(1):32-9
pubmed: 22885261
Sci Rep. 2016 Jun 09;6:27663
pubmed: 27278716
Trop Med Infect Dis. 2019 Jul 25;4(3):
pubmed: 31349636
Am J Trop Med Hyg. 2011 Jul;85(1):158-61
pubmed: 21734142
Lancet Infect Dis. 2010 Aug;10(8):545-55
pubmed: 20637696
Emerg Infect Dis. 2011 Aug;17(8):1349-54
pubmed: 21801609
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e47-54
pubmed: 23075916
Cad Saude Publica. 2012 Nov;28(11):2189-97
pubmed: 23147960
PLoS One. 2013 Oct 21;8(10):e78030
pubmed: 24205075
PLoS One. 2012;7(8):e43656
pubmed: 22937071
Virol J. 2011 Jul 27;8:371
pubmed: 21794131
Travel Med Infect Dis. 2011 Sep;9(5):246-8
pubmed: 21778117
PLoS Negl Trop Dis. 2012;6(8):e1760
pubmed: 22880140
Sci Rep. 2019 Sep 20;9(1):13626
pubmed: 31541167
Trans R Soc Trop Med Hyg. 2015 Nov;109(11):717-22
pubmed: 26385938
J Microbiol Immunol Infect. 2013 Oct;46(5):358-65
pubmed: 23041057
PLoS Negl Trop Dis. 2016 Oct 26;10(10):e0004981
pubmed: 27783626
PLoS Negl Trop Dis. 2015 Apr 29;9(4):e0003733
pubmed: 25923210
J Vector Borne Dis. 2014 Sep;51(3):153-64
pubmed: 25253207
PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2520
pubmed: 24386496
N Engl J Med. 2012 Apr 12;366(15):1423-32
pubmed: 22494122
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):319-30
pubmed: 15225982
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2311
pubmed: 23875046
Paediatr Int Child Health. 2012 May;32 Suppl 1:18-21
pubmed: 22668445
MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):504-7
pubmed: 23784016
Ecotoxicol Environ Saf. 2008 May;70(1):147-53
pubmed: 17532467
Am J Trop Med Hyg. 2019 Jan;100(1):170-173
pubmed: 30457092
Front Immunol. 2014 Jun 11;5:280
pubmed: 24966859
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):6-13
pubmed: 18165469
PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2412
pubmed: 24086778
Bull World Health Organ. 2008 May;86(5):365-72
pubmed: 18545739
Geospat Health. 2014 Nov;9(1):119-30
pubmed: 25545930
N Engl J Med. 2015 Sep 24;373(13):1195-206
pubmed: 26214039
PLoS One. 2011 Jan 18;6(1):e16085
pubmed: 21267459
Int J Epidemiol. 2012 Aug;41(4):977-87
pubmed: 22933646
Int J Infect Dis. 2010 Nov;14(11):e967-73
pubmed: 20800525
J Infect Dis. 2016 Sep 15;214(6):836-44
pubmed: 26984143

Auteurs

Alastair I Matheson (AI)

Department of Global Health, University of Washington, Seattle, Washington.
Department of Epidemiology, University of Washington, Seattle, Washington.

Ondari D Mogeni (OD)

Centre for Global Health Research, Kenya Medical Research Institute, Nairobi, Kenya.

Joshua R Lacsina (JR)

Department of Medicine, University of Washington, Seattle, Washington.

Melvin Ochieng (M)

Kenya Medical Research Institute/Centers for Disease Control and Prevention, Nairobi, Kenya.

Allan Audi (A)

Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.

Godfrey Bigogo (G)

Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.

John Neatherlin (J)

Kenya Medical Research Institute/Centers for Disease Control and Prevention, Nairobi, Kenya.

Harold S Margolis (HS)

Dengue Branch, Division of Vectorborne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Barry Fields (B)

Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.

Petronella Ahenda (P)

School of Public Health, Texas A&M University, College Station, Texas.

Judd L Walson (JL)

Department of Medicine, University of Washington, Seattle, Washington.
Department of Global Health, University of Washington, Seattle, Washington.
Department of Epidemiology, University of Washington, Seattle, Washington.

Joel M Montgomery (JM)

Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH